Q3 2017 EPS Estimates for Wright Medical Group N.V. Decreased by Northcoast Research (NASDAQ:WMGI)

Wright Medical Group N.V. (NASDAQ:WMGI) – Investment analysts at Northcoast Research lowered their Q3 2017 earnings per share (EPS) estimates for shares of Wright Medical Group N.V. in a research report issued to clients and investors on Wednesday, according to Zacks Investment Research. Northcoast Research analyst D. Keiser now anticipates that the medical device company will post earnings per share of ($0.17) for the quarter, down from their previous estimate of ($0.16).

Several other brokerages also recently issued reports on WMGI. Oppenheimer Holdings, Inc. set a $30.00 price target on shares of Wright Medical Group N.V. and gave the stock a “hold” rating in a report on Thursday, August 3rd. Jefferies Group LLC reissued a “buy” rating on shares of Wright Medical Group N.V. in a research note on Friday, November 3rd. BidaskClub cut shares of Wright Medical Group N.V. from a “hold” rating to a “sell” rating in a research note on Saturday, August 5th. Royal Bank of Canada reaffirmed a “buy” rating and set a $30.00 price target on shares of Wright Medical Group N.V. in a research report on Thursday, November 2nd. Finally, BMO Capital Markets cut their price target on shares of Wright Medical Group N.V. from $34.00 to $31.00 and set an “outperform” rating on the stock in a research report on Thursday, November 2nd. Six equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $32.22.

WARNING: “Q3 2017 EPS Estimates for Wright Medical Group N.V. Decreased by Northcoast Research (NASDAQ:WMGI)” was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this story on another publication, it was illegally copied and republished in violation of U.S. and international copyright and trademark laws. The original version of this story can be viewed at https://www.dispatchtribunal.com/2017/11/11/wright-medical-group-n-v-wmgi-to-post-q3-2017-earnings-of-0-17-per-share-northcoast-research-forecasts.html.

Shares of Wright Medical Group N.V. (WMGI) traded down $0.36 during trading hours on Friday, hitting $23.72. 723,800 shares of the stock traded hands, compared to its average volume of 1,045,701. The company has a debt-to-equity ratio of 1.52, a current ratio of 1.31 and a quick ratio of 0.96. Wright Medical Group N.V. has a 52 week low of $22.14 and a 52 week high of $31.53.

Wright Medical Group N.V. (NASDAQ:WMGI) last announced its quarterly earnings data on Wednesday, November 1st. The medical device company reported ($0.16) EPS for the quarter, meeting the consensus estimate of ($0.16). The business had revenue of $170.50 million during the quarter, compared to the consensus estimate of $173.50 million. Wright Medical Group N.V. had a negative net margin of 38.40% and a negative return on equity of 6.27%. The company’s revenue was up 8.4% on a year-over-year basis. During the same period in the previous year, the business earned ($0.19) earnings per share.

Hedge funds have recently modified their holdings of the company. Blue Jay Capital Management LLC boosted its holdings in Wright Medical Group N.V. by 4.7% in the 2nd quarter. Blue Jay Capital Management LLC now owns 320,420 shares of the medical device company’s stock worth $8,808,000 after buying an additional 14,255 shares during the period. Victory Capital Management Inc. boosted its holdings in Wright Medical Group N.V. by 30.6% in the 2nd quarter. Victory Capital Management Inc. now owns 1,039,308 shares of the medical device company’s stock worth $28,571,000 after buying an additional 243,630 shares during the period. Capital Research Global Investors boosted its holdings in Wright Medical Group N.V. by 60.9% in the 2nd quarter. Capital Research Global Investors now owns 2,775,000 shares of the medical device company’s stock worth $76,285,000 after buying an additional 1,050,000 shares during the period. Northern Trust Corp boosted its holdings in Wright Medical Group N.V. by 3.4% in the 2nd quarter. Northern Trust Corp now owns 1,865,977 shares of the medical device company’s stock worth $51,296,000 after buying an additional 60,840 shares during the period. Finally, Westfield Capital Management Co. LP boosted its holdings in Wright Medical Group N.V. by 13.8% in the 2nd quarter. Westfield Capital Management Co. LP now owns 2,425,566 shares of the medical device company’s stock worth $66,679,000 after buying an additional 293,687 shares during the period.

About Wright Medical Group N.V.

Wright Medical Group, Inc is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S., International and BioMimetic.

Get a free copy of the Zacks research report on Wright Medical Group N.V. (WMGI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Wright Medical Group N.V. (NASDAQ:WMGI)

Receive News & Ratings for Wright Medical Group N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group N.V. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply